Literature DB >> 13117684

Syndrome simulating collagen disease caused by hydralazine (Apresoline).

H M PERRY, H A SCHROEDER.   

Abstract

Entities:  

Keywords:  COLLAGEN DISEASES/etiology and pathogenesis; HYPERTENSION/therapy; SYMPATHOLYTICS/injurious effects

Mesh:

Substances:

Year:  1954        PMID: 13117684     DOI: 10.1001/jama.1954.02940420032009

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN: 0002-9955


× No keyword cloud information.
  28 in total

1.  Prolonged hydralazine hydrochloride administration in 132 hypertensive patients--Study of toxicity.

Authors:  G PIGEON; J GENEST
Journal:  Can Med Assoc J       Date:  1960-10-01       Impact factor: 8.262

2.  [On the neurological syndrome in the framework of lupus erythematosus].

Authors:  W FUHRMANN; J NAWROTZKI
Journal:  Dtsch Z Nervenheilkd       Date:  1959

3.  Rheumatoid arthritis and systemic lupus erythematosus.

Authors:  M BATEMAN; J M MALINS; M J MEYNELL
Journal:  Ann Rheum Dis       Date:  1958-03       Impact factor: 19.103

4.  The L.E. (lupus erythematosus) cell reaction.

Authors:  M A OGRYZLO
Journal:  Can Med Assoc J       Date:  1956-12-15       Impact factor: 8.262

5.  [New drugs for the management of hypertension].

Authors:  R W GIFFORD
Journal:  Klin Wochenschr       Date:  1956-01-15

6.  Drug Treatment of Hypertension.

Authors: 
Journal:  Br Med J       Date:  1954-06-19

7.  Lupus erythematosus cells in systemic sclerosis.

Authors:  N R ROWELL
Journal:  Ann Rheum Dis       Date:  1962-03       Impact factor: 19.103

8.  COMPLETELY HEALED DISSECTION OF THE AORTA WITH DEATH FROM PHLEGMONOUS COLITIS.

Authors:  T D Kellaway
Journal:  Br Heart J       Date:  1963-07

9.  Further evidence for an acetylator phenotype difference in the metabolism of hydralazine in man.

Authors:  V Facchini; J A Timbrell
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

10.  Induction of antibodies to nuclear antigens in rabbits by immunization with hydralazine-human serum albumin conjugates.

Authors:  Y Yamauchi; A Litwin; L Adams; H Zimmer; E V Hess
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.